<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
 

Target Identification
and Validation

The advent of fast and reliable next-generation technologies for the genomic and proteomic characterization of biological specimens has contributed to the identification and validation of a wealth of targets that can be potentially exploited for treating cancer. However, an in-depth molecular understanding of cellular processes is required to transition potential targets into pharmacological candidates.

Identify and Validate the Function of Biological Targets

At Crown Bioscience, we use a comprehensive tool set to determine the biological functions of each target as well as the consequences of pharmacological intervention.

in vitro
In Vitro Models

Accelerate target ID and validation with 500+ validated cell lines and exclusive HUB organoids.

in vivo
In Vivo Models

Unlock target-specific biomarkers and assess your agent’s impact on tumor growth with our unique models.

Human Biospecimens
Human Biospecimens

Access IRB-approved human biospecimens preserving molecular fidelity for breakthrough oncology research.

Genomics and Transcriptomics
Genomics and Transcriptomics

Reveal new drug targets with high-quality genomics and transcriptomics backed by automated, reproducible workflows.

Target KO and CRISPR
Target KO and CRISPR

Confidently model cancer and assess drug efficacy with our CRISPR-licensed platform.

Proteomics
Proteomics

Leverage high-resolution MS-based proteomics for sensitive, reproducible insights into complex biology.

In Silico Solutions
In Silico Solutions

Power drug discovery with in silico solutions to optimize targets and streamline therapeutic design.

Discuss Your Target ID and Validation Project

From in vitro and in vivo models to in silico insights, genomics, proteomics, and exclusive biobank resources, we deliver the integrated solutions you need to discover, validate, and advance the next generation of therapies. Contact us today to accelerate your breakthroughs.